NCT05151510

Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

A Randomized Controlled Study Comparing Trigger Point Injections With 1% Lidocaine Versus 5% Lidocaine Patch for Myofascial Pain in the Emergency Department

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of California, Irvine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The aim of this trial is to investigate the efficacy of trigger point injections with 1% lidocaine in reducing myofascial back and neck pain in the Emergency Department compared to lidocaine patches 5%.

Detailed description

After being informed about the study and the potential risks and benefits, all patients will be randomized into either the trigger point injection group with 1% lidocaine, or the 5% lidocaine patch group. Pain scores will be recorded while in the emergency department, and we will have a 5 day follow-up phone call to assess efficacy. Patients who present to UCI Department of Emergency medicine will be screened and recruited prospectively, and information regarding this study will be available on clinicaltrials.gov as a method of recruitment.

Conditions

• Myofascial Trigger Point Pain
• Myofacial Pain

Interventions

Type	Name	Description
PROCEDURE	Trigger point injection with 1% lidocaine	Previously discussed in prior section.
DRUG	Lidocaine patch 5%	Will place lidocaine patch onto skin overlaying point of maximal tenderness

Timeline

• Start date: 2021-11-01
• Primary completion: 2022-06-30
• Completion: 2022-06-30
• First posted: 2021-12-09
• Last updated: 2026-02-13

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study